Almirall SA (ALMRY)
14.28
0.00 (0.00%)
USD |
OTCM |
May 19, 16:00
Almirall EPS Diluted (Quarterly) : 0.0833 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Laboratorios Farmaceúticos Rovi SA | 0.2168 |
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.90M |
| Revenue (Quarterly) | 340.45M |
| Total Expenses (Quarterly) | 322.55M |
| Enterprise Value | 3.036B |
| Earnings Yield | 1.70% |
| Operating Earnings Yield | 2.47% |
| Normalized Earnings Yield | 1.386 |